The hubris and humility of cancer pharmacology in the post immuno‐oncology era
Abstract Cancer is a dreaded word, which has stimulated monumental efforts to discover and deliver effective cancer treatments for more than half a century. During the past two decades, our understanding of the molecular pathogenesis of cancer has increased remarkably. This has fostered an explosion...
Saved in:
Main Author: | John S. Lazo (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lessons in humility
by: The Lancet Global Health
Published: (2021) -
Immune landscape and biomarkers for immuno-oncology in colorectal cancers
by: Jeong Mo Bae, et al.
Published: (2020) -
The "art" of teaching study skills: a teacher or a student as a homo hubris in media space?
by: Marta Wrońska
Published: (2021) -
Lung cancer - the role of immuno-oncology and the importance of pembrolizumab in its therapy
by: Jakub Jarosz, et al.
Published: (2023) -
Strategic Consensus on the Value of Immuno-Oncology in Portugal
by: . .
Published: (2016)